2212-76-2 Usage
Description
Z-LYS(BOC)-OH DCHA, also known as N-benzyloxycarbonyl-L-lysine dicyclohexylammonium hydroxide, is a chemical compound that serves as an intermediate in the synthesis of various pharmaceuticals. It is characterized by its white crystalline appearance and plays a crucial role in the development of potential neuroprotective agents.
Uses
Used in Pharmaceutical Industry:
Z-LYS(BOC)-OH DCHA is used as a pharmaceutical intermediate for the preparation of dimeric dipeptide nerve growth factor mimetics. These mimetics have the potential to act as neuroprotective agents, offering therapeutic benefits in the treatment of neurological disorders and conditions.
As a key component in the synthesis of nerve growth factor mimetics, Z-LYS(BOC)-OH DCHA contributes to the development of novel therapeutic strategies for neurodegenerative diseases, such as Alzheimer's, Parkinson's, and multiple sclerosis. Its role in the pharmaceutical industry highlights its importance in advancing the field of neuroprotection and promoting overall brain health.
Check Digit Verification of cas no
The CAS Registry Mumber 2212-76-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,2,1 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 2212-76:
(6*2)+(5*2)+(4*1)+(3*2)+(2*7)+(1*6)=52
52 % 10 = 2
So 2212-76-2 is a valid CAS Registry Number.
InChI:InChI=1/C19H28N2O6.C12H23N/c1-19(2,3)27-17(24)20-12-8-7-11-15(16(22)23)21-18(25)26-13-14-9-5-4-6-10-14;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h4-6,9-10,15H,7-8,11-13H2,1-3H3,(H,20,24)(H,21,25)(H,22,23);11-13H,1-10H2/t15-;/m0./s1
2212-76-2Relevant articles and documents
PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES
-
Page/Page column 17-18, (2008/06/13)
A process for the preparation of ω-alkoxycarbonylamino-α-aminoacids and α,ω orthogonally diprotected diaminoacids from α,ω-diaminoacids using 1- alkoxycarbonylbenzotriazoles as protecting agents is disclosed. In an alternative embodiment, carbamoylating agents in the presence of benzotriazoles are used instead of 1-alkoxycarbonylbenzotriazoles. This reaction is preferably applied to the preparation of ε- alkoxycarbonyllysines from lysine. A process for the preparation of t-butoxycarbonylbenzotriazoles and novel complexes of ω-alkoxycarbonylamino-α-aminoacids with benzotriazoles are also disclosed.